Last reviewed · How we verify
NCT05475145: SealCar
Sealing of Occlusal Dentin Caries in Primary Molars.
NA trial testing Resin based sealing [RBS] in Caries; Dentin in 70 participants. Completed in 17 June 2022.
17 June 2021
Quick facts
| Lead sponsor | Mats Bågesund |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 2 February 2015 |
| Primary completion | 17 June 2021 |
| Estimated completion | 17 June 2022 |
Drugs / interventions tested
- Resin based sealing [RBS]
Conditions studied
- Caries; Dentin — all drugs for Caries; Dentin →
- Fissure, Dental — all drugs for Fissure, Dental →
- Dental Caries in Children — all drugs for Dental Caries in Children →
- Glass Ionomer Cement — all drugs for Glass Ionomer Cement →
Sponsor
Mats Bågesund
Who can join
Adults 3 to 9, any sex, with Caries; Dentin or Fissure, Dental. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
BACKGROUND A simple method for arresting dentin caries with a tight seal of the cavity would exclude the need for injection and excavation, reduce the risk for dental fear and possibly postpone or eliminate the need for further treatment. AIM The aim is to evaluate success-rate and children's subjective experience of resin-based sealing (RBS) and resin-modified glass ionomer cement (GIC) for treatment of occlusal dentin caries in primary molars. DESIGN Children aged 2-9 years will be recruited to undergo RBS- or GIC-treatment treatment for occlusal dentin caries in primary molars. A parent will answer the Short Form of Children's Fear Survey (CFSS-DS; parental version). No excavation but etching with 38% phosphoric acid will precede RBS. Topical and local anaesthesia and excavation with high speed bur will precede GIC. Time for treatment will be estimated. The children will rank their experience of each treatment on a 7-grade face scale. The dentist will evaluate the child's experience, cooperation and the overall experience of the treatment on a four-grade scale. The treatment will be evaluated as "without remark" or "defective" after 3, 6, 12, 24 and 36 months. For statistical analysis the Chi-2-test, Wilcoxon-Signed-Rank-test and Paired t-test will be used.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Resin-based sealing vs resin-modified glass-ionomer filling for treatment of occlusal cavitated dentine caries lesions in primary molars - a multi-center randomized controlled split-mouth 3-year follow-up clinical trial.
Bågesund M, Olson AC, Chizarie S, Omanovic M, et al · · 2026 · PMID 41520098 · DOI 10.1007/s40368-026-01161-7
Verify or expand the search:
- PubMed search for NCT05475145
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Caries; Dentin
Currently open trials in the same condition.
- NCT06645860 — SMART With Different Modifications in Asymptomatic Deep Carious Lesions of Primary Molars. · NA · recruiting
Other Mats Bågesund trials
Trials by the same sponsor.
- NCT04389905 — Equal Oral Health in Children: The Hageby-model · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05475145 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mats Bågesund
- Last refreshed: 26 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05475145.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing